COVID-19 and Kawasaki disease in 4-year-old child; a case report

Although Kawasaki disease-like syndromes have previously been linked to other viral infections, these patients showed higher levels of pro-inflammatory markers than other cohorts, which may reflect a particularly strong immunological reaction to SARS-CoV-2. This article examines a case of comorbidity between Kawasaki and Covid 19 in a 4-year-old child who complained of fever. 

We describe the case of a 4-year-old child admitted and diagnosed with classic Kawasaki disease, who also screened positive for COVID-19 in the setting of fever and minimal respiratory symptoms. The patient was treated per treatment guidelines, with intravenous immunoglobulin and high-dose aspirin, and subsequently defervesced with resolution of her clinical symptoms. with instruction to quarantine at home for 14 days from the date of her positive test results for COVID-19.

Consideration of the results of this case report is essential for other pediatric care professionals with COVID-19, as understanding of clinical demonstration patterns continues to evolve. For more information on the clinical course of children with COVID-19, Especially in cases where the disease coincides with Kawasaki, it is necessary.